Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC

Biotechnology • Healthcare • Altrincham, United Kingdom • CNTA (NMS)

Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines. Its lead clinical-stage program includes ORX750, an orally administered OX2R agonist in a Phase 2a study for the treatment of idiopathic hypersomnia and narcolepsy type 1 and 2. The company also develops ORX142 for the treatment of neurological and neurodegenerative disorders, as well as other potential symptoms, including excessive daytime sleepiness, impaired attention, cognitive deficits, and fatigue; and ORX489 for the treatment of neuropsychiatric disorders. In addition, it offers LockBody, which is designed to selectively drive potent effector function activity, such as CD3, into the tumor microenvironment. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.

1 Ashley Road, United Kingdom

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Centessa Pharmaceuticals (CNTA): Revisiting Valuation After Strong ORX750 Phase 2 Data and Leadership Shift - Yahoo Finance
Yahoo Finance • Dec 11
Analysts boost Centessa Pharmaceuticals plc (CNTA) price targets as sleep disorder drug shows breakthrough results - MSN
MSN • Dec 9
Why Centessa Pharmaceuticals Stock Crushed the Market Today - The Motley Fool
The Motley Fool • Nov 12
Analysts Are Bullish on These Healthcare Stocks: Palisade Bio (PALI), Centessa Pharmaceuticals (CNTA) - The Globe and Mail
The Globe and Mail • Jan 1
Centessa Pharmaceuticals plc Announces Underwritten Public Offering of American Depositary Shares - Quiver Quantitative
Quiver Quantitative • Nov 11

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Centessa Pharmaceuticals plc had layoffs?
No layoff events have been recorded for Centessa Pharmaceuticals plc in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Centessa Pharmaceuticals plc have?
Centessa Pharmaceuticals plc has approximately 114 employees.
What industry is Centessa Pharmaceuticals plc in?
Centessa Pharmaceuticals plc operates in the Biotechnology industry, within the Healthcare sector.
Is Centessa Pharmaceuticals plc a publicly traded company?
Yes, Centessa Pharmaceuticals plc is publicly traded under the ticker symbol CNTA on the NMS. The company has a market capitalization of approximately $3.70 billion.
Where is Centessa Pharmaceuticals plc headquartered?
Centessa Pharmaceuticals plc is headquartered in Altrincham, United Kingdom at 1 Ashley Road, United Kingdom.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.